The TCBridge (Trauma Custom Bridge) system, jointly developed by the team of Professor Tian Yun from the Department of Orthopedics of Peking University Third Hospital and Beijing Aikang Yicheng Medical Equipment Co., Ltd., was approved by the State Food and Drug Administration. The customized long-segment bone defect restoration system fills the gap in the industry.
The approval of the TCBridge system marks a safer and more effective solution for the repair and reconstruction of large bone defects in the extremities, and also marks a new step in the repair and reconstruction technology of trauma orthopedics.
Professor Tian Yun said, "The successful listing of the TCBridge system has benefited from the deep technical accumulation of 3D printing technology in the field of orthopedics. It is the result of multi-dimensional cooperation such as research, applied research, original research and development, and technological upgrading."
The TCBridge system is supported by the key project of the Beijing Municipal Science and Technology Commission "Clinical Application Research of 3D Printing Porous Titanium Alloys in the Treatment of Large Segmental Bone Defects of Limbs". It is a customized trauma reconstruction system developed by Professor Tian Yun's team after 5 years of exploration and efforts The first approved product of TCR-Trauma Custom Reconstruction.
